Skip to menu
Skip to content
Skip to footer
Menu
Study
Research
Partners and community
About
Search
Australian Infectious Diseases Research Centre
Home
About
About
The global imperative for infectious disease research
Background
AID - a network centre
Mission and Goals
Issues we address
Expected outcomes
Donate
AID Research Management Committee
AID Scientific Advisory Board
Research
Research
Clinical genomics
Therapeutic development
Respiratory polymicrobial infections
Diagnostics
Antimicrobial resistance
Emerging infectious diseases
Host-pathogen interactions
Vaccine development
Investigators
Partners
News & Events
Contact
NHMRC Investigators
Study
Research
Partners and community
About
UQ home
News
Events
Give
Contact
Search term
UQ home
News
Events
Give
Contact
Australian Infectious Diseases Research Centre
Menu
Home
About
Show About sub-navigation
The global imperative for infectious disease research
Background
AID - a network centre
Mission and Goals
Issues we address
Expected outcomes
Donate
AID Research Management Committee
AID Scientific Advisory Board
Research
Show Research sub-navigation
Clinical genomics
Therapeutic development
Respiratory polymicrobial infections
Diagnostics
Antimicrobial resistance
Emerging infectious diseases
Host-pathogen interactions
Vaccine development
Investigators
Partners
News & Events
Contact
NHMRC Investigators
News & Events
Eureka Prize 2024 finalists announced
Calculate your personal long COVID risk
UQ develops new drug for sepsis
Blood analysis predicts sepsis and organ failure in children
UQ partners in global vaccine hub in Queensland
Researchers infect a ‘brain in a dish’ in search for Zika antivirals
Research identifies potential new treatment for all COVID-19 variants
Researchers discover way to disarm potentially deadly Listeria bacteria
Scientists uncover ‘resistance gene’ in deadly E. coli
SPARKing the fight against deadly superbugs
Over $6 million in NHMRC grants for the GVN Center of Excellence at the AIDRC
$1.25 million fellowship to develop rapid pandemic treatments
Oral hookworm vaccine could save millions around the world
COVID-19 killing coating a spray away
Pandemic proofing our future
CARB-X is funding UQ to develop a new antibacterial drug to treat drug-resistant infections in low- and middle-income countries
New defence against dengue and emerging mosquito-borne viruses
United in science
NHMRC funding to fight infectious disease
Alzheimer's disease drug may help fight against antibiotic resistance
AIDRC research identifies links in high cholesterol and protective infection outcomes
Funding allows researchers to uncover the secrets of COVID-19 immunity
UQ congratulates Vaxxas on $30m partnership
Supercharged ‘clones’ spark scarlet fever’s re-emergence
Landmark deal for UQ-Trinity inflammation startup
Discovery promising for millions at risk from antibiotic resistance
International partnership progresses UQ COVID-19 vaccine project
$17m shot in the arm for UQ's COVID-19 vaccine research
Researchers race to accelerate UQ's COVID-19 vaccine research
Researchers set to begin clinical trials on coronavirus cure
'Significant step' in COVID-19 vaccine quest
Lung transplant survivor beats the odds through ground breaking treatment
Race to develop coronavirus vaccine
Second antibiotic no advantage for treating super-bug Golden Staph
Safer viruses for vaccine research and diagnosis
CDC Antibiotic Resistance Threats in the United States
RSV vaccine gets the injection it needs
Bacterial defence construction revealed in step forward for new antibiotics
UQ researcher elected to eminent European scientific organisation
Vaccine one step closer for one of the world’s biggest killers
Queensland researchers join international search for new antibiotics
Zika study may ‘supercharge’ vaccine research
Zinc could help as non-antibiotic treatment for UTIs
Partnership to supercharge vaccine production
Alzheimer’s drug may help battle antibiotic resistance
Kirsty's success going viral
U.S. Challenges World to Intensify Global Fight against Antibiotic Resistance
Potential medical breakthroughs receive national funding
Nature to lead fight against tuberculosis
Bird flu study to probe genetic immunity of species
Funding fights antibiotic resistance
‘Forgotten’ antibiotic offers hope against worst superbugs
Nanopatch polio vaccine delivers
UQ study targets lethal fungal infection
Dangerous bacteria a true survivor
Order of Australia for AID member
A step towards understanding Zika
ASID Annual Scientific Meeting 2017
New protein offers hope for HIV cure
Queensland researchers unite to fight Zika
Deadly ‘Crypto’ pathogen lures Fulbright researcher to UQ
Australian virus might be answer to effective Ebola vaccine
Lorne Infection & Immunity conference 2015
Nanopatch vaccine technology company attracts $25 million
Evolving superbug threatens to create an infection tsunami
Spate of Mideast virus infections raises concerns
DNA research revealing ‘libraries’ of information
Researchers develop new methods to keep resistant gonorrhoea in check
Tiny sensor could lead to better superbug drugs
Pandemic Potential Seen in Gene Changes of Bird Flu
Tracking Superbugs to their source
Members of our Research Centre hail potential cure for AIDS
AID member receives Grand Challenges Explorations grant
New vaccine delivery company starts with AUD15 million investment
AID is officially launched
AID Sponsors national prize